Key Findings
A new research paper posted on medRxiv raises critical concerns about the reliability of Vision-Language Models (VLMs) in mammography, suggesting that conventional accuracy metrics may significantly overstate the trustworthiness of their underlying evidence grounding. The study introduces a novel ‘evidence-based selective evaluation benchmark’ that assesses not only pathology classification and anomaly identification but also demands label-aware lesion localization. After evaluating 16 different VLMs, the researchers found a substantial gap between a model’s classification performance and the reliability of its evidence-based reasoning, indicating a potential overestimation of current VLM trustworthiness in clinical contexts.
Technical / Clinical Details
The proposed evaluation benchmark moves beyond simple classification accuracy by requiring VLMs to precisely localize the visual evidence (e.g., specific lesion areas in a mammogram) that underpins their diagnostic conclusions. This approach helps identify instances where a VLM might arrive at a ‘correct’ answer through spurious correlations or statistical patterns rather than true visual understanding and evidence-based reasoning. The evaluation of 16 VLMs revealed that models with high classification accuracy often exhibited poor lesion localization capabilities and lacked robust explainability for their diagnostic rationales. This disconnect suggests that VLMs might not truly ‘understand’ the pathology they are identifying, potentially increasing the risk of misdiagnosis or unreliable outputs in real-world clinical applications where transparent and verifiable reasoning is paramount.
Background & Context
AI, particularly VLMs, holds immense promise for transforming medical imaging diagnostics, with mammography being a key application area for early cancer detection. AI-powered diagnostic support is envisioned to reduce physician workload and improve diagnostic accuracy. However, the integration of AI into healthcare demands uncompromising standards for reliability, transparency, and explainability. It is not sufficient for an AI to merely achieve high accuracy; clinicians need to understand why a particular conclusion was reached and the visual evidence supporting it. This research highlights inherent limitations in current VLM evaluation methodologies, underscoring the urgent need for more rigorous and multifaceted assessment criteria to ensure medical AI’s safe and effective clinical adoption.
Strategic Significance & Outlook
These findings have significant implications not only for mammography VLMs but also for the broader development and evaluation of AI models in other medical imaging domains. Future efforts must focus on improving VLM architectures to enhance their evidence grounding, localization capabilities, and explainability. The adoption of more robust evaluation benchmarks, similar to the one proposed, will be crucial. For clinicians to confidently and safely integrate AI into their diagnostic workflows, AI systems must provide clear, verifiable justifications for their conclusions, moving beyond mere ‘hit rates’ to demonstrate true clinical utility and trustworthiness. This study represents a vital step toward building quality assurance and fostering confidence in medical AI tools for practical clinical deployment.
Source: https://www.medrxiv.org/content/10.64898/2026.09.10.26361944v1
Get our weekly technology intelligence — free
Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.
Subscribe Free — Weekly Tech Intelligence
By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.
- Your email and selected fields are used only to deliver the newsletter.
- We never share your information with third parties.
- You can unsubscribe anytime via the link in each email.
See our Privacy Policy for details.
Takes about a minute · Unsubscribe anytime

Comments